Scinai Immunotherapeutics Ltd. Held Annual Shareholder Meeting
I'm PortAI, I can summarize articles.
Scinai Immunotherapeutics Ltd. held its Annual Meeting of Shareholders on December 22, 2025. Shareholders approved the re-election of Mark Germain to the board, a voluntary agreement for certain board members to step down, a grant of American Depository Shares to Dr. Tamar Ben-Yedidia, and the appointment of Zvi Haft as the company’s auditors for 2025.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments